Researchers analyzed data patients with COPD, hospitalized with any acute respiratory illness or exacerbation between 2011 and 2015. All patients were tested for the flu.
Of 4,755 hospitalized patients with COPD, 88.3 percent had a known vaccination status. The study shows that patients who received the flu vaccine experienced a 38 percent reduction in flu-related hospitalizations as compared to unvaccinated patients.
“Initiatives to increase vaccination uptake and early use of antiviral agents among patients with COPD could reduce influenza-related hospitalization and critical illness and improve healthcare costs in this vulnerable population,” study authors wrote.
More articles on healthcare quality:
Researchers uncover key step to how antibiotic resistance spreads in hospitals
Brooklyn enclave shows how communities drive antibiotic resistance
Viewpoint: 4 moments to change how antibiotics are prescribed
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
